AMSTERDAM — Vitestro, a Dutch medical robotics firm, announced today it has secured an additional $70 million in funding to accelerate the development of its autonomous blood collection device. The company assures future patients that the robot will not engage in awkward small talk or feign concern over your fear of needles, focusing instead on optimizing the venipuncture process with cold, hard data.

“Our goal is to eliminate the human element entirely,” stated Dr. Aris Thorne, Vitestro’s Head of Clinical Detachment. “No more searching for a good vein, no more comforting words. Just a swift, precise insertion based on advanced imaging and AI, followed by an efficient extraction. We believe patients will appreciate the consistency, even if it means feeling slightly less… human.”

Industry analysts suggest the move is a response to the growing demand for healthcare efficiency and the dwindling supply of phlebotomists willing to tolerate the emotional labor of dealing with squeamish adults. “Why pay a person to make eye contact when a robot can do it faster and never call in sick?” remarked financial pundit Brenda Sterling. “The future of healthcare is less about care and more about throughput.”

Vitestro anticipates the robot will also be capable of silently judging your hydration levels and overall health choices, though this feature is currently in beta testing.